de Lera Ruiz; Manuel

Patent Applications and Registrations

Patent applications and USPTO patent grants for de Lera Ruiz; Manuel.The latest application filed is for "phosphinic amide prodrugs of tenofovir".

Company Profile

1.17.23

de Lera Ruiz; Manuel - Perkasie PA
de Lera Ruiz; Manuel - Branchburg NJ
De Lera Ruiz; Manuel - Kenilworth NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antiviral benzyl-amine phosphodiamide compounds Grant 11,123,355 - de Lera Ruiz , et al. September 21, 2	2021-09-21
Phosphinic Amide Prodrugs Of Tenofovir App 20210260082 - De Lera Ruiz; Manuel ; et al.	2021-08-26
2,2-difluorodioxolo A.sub.2A receptor antagonists Grant 11,046,714 - Amjad , et al. June 29, 2	2021-06-29
Antiviral Benzyl-amine Phosphodiamide Compounds App 20190321380 - de Lera Ruiz; Manuel ; et al.	2019-10-24
Aminoquinazoline compounds as A.sub.2A antagonist Grant 10,138,212 - Ali , et al. Nov	2018-11-27
Aminoquinazoline Compounds As A2a Antagonist App 20180037554 - Ali; Amjad ; et al.	2018-02-08
2,2-difluorodioxolo A2a Receptor Antagonists App 20160214997 - Amjad; Ali ; et al.	2016-07-28
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators Grant 8,569,312 - McCormick , et al. October 29, 2	2013-10-29
Biaryl-spiroaminooxzaoline Analogues As Alpha 2c Adrenergic Receptor Modulators App 20130225582 - McCormick; Kevin D. ; et al.	2013-08-29
Functionally selective alpha2C adrenoreceptor agonists Grant 8,501,747 - de lera Ruiz , et al. August 6, 2	2013-08-06
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators Grant 8,476,274 - McCormick , et al. July 2, 2	2013-07-02
Reversed Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators App 20130079271 - McCormick; Kevin D. ; et al.	2013-03-28
Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators App 20130045914 - McCormick; Kevin D. ; et al.	2013-02-21
Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators Grant 8,324,213 - McCormick , et al. December 4, 2	2012-12-04
Biaryl-spiroaminooxazoline Analogues As Alpha 2c Adrenergic Receptor Modulators App 20110251207 - McCormick; Kevin D. ; et al.	2011-10-13
Cyclopropylchromene Derivatives As Modulators Of The Alpha-2c Receptor App 20110190247 - Yu; Younong ; et al.	2011-08-04
ALPHA2C adrenoreceptor agonists Grant 7,985,748 - McCormick , et al. July 26, 2	2011-07-26
Tricyclic Spirocycle Derivatives And Methods Of Use App 20110166124 - McCormick; Kevin D. ; et al.	2011-07-07
Tricyclic Heterocyclic Derivatives and Methods of Use App 20110136790 - De Lera Ruiz; Manuel ; et al.	2011-06-09
Bicyclic Heterocylic Derivatives and Methods of Use App 20110130385 - De Lera Ruiz; Manuel ; et al.	2011-06-02
Substituted aniline derivatives useful as histamine H3 antagonists Grant 7,879,880 - Solomon , et al. February 1, 2	2011-02-01
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists Grant 7,846,946 - Aslanian , et al. December 7, 2	2010-12-07
Functionally Selective Alpha2c Adrenoreceptor Agonists App 20100197562 - De lera Ruiz; Manuel ; et al.	2010-08-05
Alpha2c Adrenoreceptor Agonists App 20100173823 - McCormick; Kevin D. ; et al.	2010-07-08
.alpha.2C adrenoreceptor agonists Grant 7,700,592 - McCormick , et al. April 20, 2	2010-04-20
Phenoxypiperidines and analogs thereof useful as histamine H.sub.3 antagonists Grant 7,638,531 - Mutahi , et al. December 29, 2	2009-12-29
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists Grant 7,635,705 - Aslanian , et al. December 22, 2	2009-12-22
Heteroatom-linked Substituted Piperidines And Derivatives Thereof Useful As Histamine H3 Antagonists App 20090286830 - Aslanian; Robert G. ; et al.	2009-11-19
1-[[1-[(2-amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbon- yl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-B]pyridin-3-YL]piperidine and methods of use thereof Grant 7,531,660 - de Lera Ruiz , et al. May 12, 2	2009-05-12
1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbon- yl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine and Methods of Use Thereof App 20080058370 - de Lera Ruiz; Manuel ; et al.	2008-03-06
1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbon- yl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine Grant 7,332,604 - de Lera Ruiz , et al. February 19, 2	2008-02-19
Alpha2C adrenoreceptor agonists App 20080039439 - McCormick; Kevin D. ; et al.	2008-02-14
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists App 20070167435 - Mutahi; Mwangi W. ; et al.	2007-07-19
Substituted aniline derivatives useful as histamine H3 antagonists App 20070142394 - Solomon; Daniel M. ; et al.	2007-06-21
Alpha2C adrenoreceptor agonists App 20070093477 - McCormick; Kevin D. ; et al.	2007-04-26
1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbon- yl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine App 20070066644 - de Lera Ruiz; Manuel ; et al.	2007-03-22
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists App 20070015807 - Aslanian; Robert G. ; et al.	2007-01-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.